Responsibilities of Test Facility Management & Sponsor Rik Hendriks Werner Coussement
|
|
|
- Doris Rogers
- 9 years ago
- Views:
Transcription
1 Responsibilities of Test Facility Management & Sponsor Rik Hendriks Werner Coussement J&J R&DQA, Beerse, Belgium J&J GPCD, Beerse, Belgium
2 Responsibilities of management & sponsor Responsible people Quality Assurance Test facility, supplies, test item, computerized systems SOP s Performance of a study OECD 1: OECD Principles of Good Laboratory Practice OECD 11: The Role and Responsibilities of the Sponsor OECD 13: Organisation and Management of Multi-Site Studies OECD 15: Archives
3 Management Definition: Test Facility Management means the person(s) who has the authority and formal responsibility for the organisation and functioning of the test facility according to GLP Identification of management Job descriptions SOP on the organisation of the test facility Sufficient number of qualified personnel, Master Schedule, appropriate facilities, equipment, and materials are available for the timely and proper conduct of the study
4 Personnel Record of the qualifications, training, experience and job description Personnel clearly understand their functions CV, Basic Training Plan SOPs and SOP training Development plan and ongoing training
5 Study Director Designate a Study Director for each study Replacement of a Study Director Study Director workload Study request form, kept in raw data Development Plan & ongoing training Described in SOPs (incl. replacement) and documented in raw data
6 Principal Investigator Multi-site study: designation of a Principal Investigator Replacement done according to established procedures, and documented Same principles as for Study Director request form, basic and on-going training, documented replacement
7 Quality Assurance Quality Assurance Program Independent reporting structure Approved document appointing QA and listing responsibilities Access to Master Schedule QA audits reported to management Inspection reports (study specific, system, CRO) Overview reporting of observations and trending with trend analysis Open communication Proactive handling, Innovative solutions, Risk Management
8 Test facility supplies Test facility supplies meet requirements appropriate to their use in a study Reagents, materials, animals, food, equipment, as much as possible from ISO certified companies vendor audits performed by QA equipment: validated, calibrated and quality controlled
9 Test and reference item Test and reference items are appropriately characterized Certificate of analysis available before the start of the study identity with batch No. purity stability storage conditions
10 Computerized systems Computerized systems are suitable for their intended purpose and validated, operated and maintained in accordance with GLP IT departement with internal preclinical IT team Validation methodology described in policy and SOPs Master Validation Plan Validation file for all computerised systems and defined change control QA audits
11 SOPs Appropriate and technically valid SOPs established and followed Approve original and revised SOPs Maintain historical file of SOPs SOP management System Procedure on how to manage SOPs Defined responsibilities for SOP owners
12 Performance of a study Documented approval of study plan Multi-site study: clear lines of communication between SD, PI, QA and study personnel Study plan is signed by SD, management signs as sponsor rep (described in SOP) Procedure on study plan distribution and documented evidence Multi-site: Described in procedures and study plan Multi-site: Documented communication
13 Archives Individual identified as responsible for management of the archive Records and materials should be archived Out of business: the archive should be transferred Archivist appointed, responsibilities described in job description Paper, material and electronic archiving described in SOPs Controlled access Described in study plan and reflected in the report Discussed and audited during CRO evaluation Described in SOP (checked during CRO evaluation)
14 Sponsor responsibilities Definition: Sponsor means an entity which commissions, supports and/or submits a non-clinical health and environmental safety study Ensure that the test facility is able to conduct the study in compliance with GLP and that it is aware that the study is to be performed under GLP Before the start of a study Preselection visits and Audits by QA/Sponsor scientists Ongoing follow-up QA audits and Study monitor visits GLP requirement described in contract & study plan
15 Sponsor responsibilities Provision of chemical safety information Characterization of the test item, carried out either by the contracted test facility or by the sponsor Submission of data to regulatory authorities: Study Director = scientific validity of a study Sponsor = make the decision, based on the outcome of the study Safety information is provided before the start of the study Certificate of analysis is provided and is part of the final report Sponsor s decision to submit final report to HA
16 Sponsor responsibilities Materials and records are retained and maintained under conditions that ensure their integrity and continued access If records and materials transferred into the sponsors possession = storage in GLP archives Study plan specifies how long data are being stored Archiving can be done internally or externally (part of CRO evaluation)
17 Common Responsibility of Health Authority and Pharma Industry Opportunity in front of us to step up together to come up with one global set of GLP Principles which in turn can lead to one global submission file. It is firmly hoped that Health Authorities and Industry, hand in hand, can actually optimize their interaction to the overall benefit of human health.
18 Thanks to my Johnson & Johnson colleagues from Global R&DQA and Global Pre-clinical Development with a special thank to Hilde Van den Eynde, Betty DeLise, Jerry Snoeks and Kirk Huber
GLP vs GMP vs GCP Dominique Pifat, Ph.D., MBA The Biologics Consulting Group [email protected]
GLP vs GMP vs GCP Dominique Pifat, Ph.D., MBA The Biologics Consulting Group [email protected] Common Misconception Good Laboratory Practices 1) A quality system concerned with the organizational process
Resources Based, Manufacturing and Consumer Goods Industries Chemicals Industry
EUROPEAN COMMISSION Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs Resources Based, Manufacturing and Consumer Goods Industries Chemicals Industry Version March 2015 QUESTIONS
Comparison Chart of FDA and EPA Good Laboratory Practice (GLP) Regulations and the OECD Principles of GLP
Comparison Chart of FDA and EPA Good Laboratory Practice (GLP) Regulations and the OECD Principles of GLP Document issued on: June 2004 U.S. Department of Health and Human Services Food and Drug Administration
OECD and US GLP Applications. Del W. Huntsinger. BASF, Reserach Triangle Park, USA [email protected]
OECD and US GLP Applications Del W. Huntsinger BASF, Reserach Triangle Park, USA [email protected] Agenda Brief Overview US GLPs OECD GLPS Similarities Differences Looking Forward OECD and US GLP
OECD Series on Principles of GLP and Compliance Monitoring Number 8 (Revised)
Unclassified ENV/JM/MONO(99)24 ENV/JM/MONO(99)24 Or. Eng. Unclassified Organisation de Coopération et de Développement Economiques OLIS : 14-Sep-1999 Organisation for Economic Co-operation and Development
Practice OECD PRINCIPLES AND GUIDANCE FOR COMPLIANCE MONITORING
«Good Laboratory Practice OECD PRINCIPLES AND GUIDANCE FOR COMPLIANCE MONITORING Good Laboratory Practice OECD PRINCIPLES AND GUIDANCE FOR COMPLIANCE MONITORING ORGANISATION FOR ECONOMIC CO-OPERATION
The Concept of Quality in Clinical Research. Dorota Śwituła Senior Clinical Quality Assurance Advisor
The Concept of Quality in Clinical Research Dorota Śwituła Senior Clinical Quality Assurance Advisor 1 Agenda What is quality? How we define quality in clinical research? The standard components of a Quality
OECD SERIES ON PRINCIPLES OF GOOD LABORATORY PRACTICE AND COMPLIANCE MONITORING Number 1
Unclassified ENV/MC/CHEM(98)17 ENV/MC/CHEM(98)17 Or. Eng. Unclassified Organisation de Coopération et de Développement Economiques OLIS : 21-Jan-1998 Organisation for Economic Co-operation and Development
ASTRAZENECA GLOBAL POLICY QUALITY AND REGULATORY COMPLIANCE
ASTRAZENECA GLOBAL POLICY QUALITY AND REGULATORY COMPLIANCE THIS POLICY OUTLINES THE TOP LEVEL REQUIREMENTS TO SUPPORT PRODUCT QUALITY IN THE DEVELOPMENT, MANUFACTURE AND DISTRIBUTION OF ACTIVE PHARMACEUTICAL
Good Research Practice
Page 1 of 8 The Royal Veterinary College Introduction Preface Good Research Practice Funding bodies need to be assured of the quality and validity of research they fund and ensure their contractors are
VERSION 7.0 01/06 OPERATIONAL HANDBOOK OF IR-4 TO FULFILL THE REQUIREMENTS OF EPA FOR GOOD LABORATORY PRACTICES
VERSION 7.0 01/06 OPERATIONAL HANDBOOK OF IR-4 TO FULFILL THE REQUIREMENTS OF EPA FOR GOOD LABORATORY PRACTICES TABLE OF CONTENTS PREFACE...i PERSONNEL GUIDELINES FOR GLP COMPLIANCE...1 GLP DEFINITIONS...2
Validation Consultant
Personal Data Name Title Validation Consultant Contact jsb-validierung Zwischen den Bächen 9 D 79618 Rheinfelden Tel: +49 7623 79 49 82 Mobile: +49 172 737 84 86 E-Mail: Internet: [email protected] http://www.jsb-validierung.de
1. Scope This SOP covers requirements for PHARMCO-AAPER s Quality Management System
Page 1 of 8 1. Scope This SOP covers requirements for PHARMCO-AAPER s Quality Management System 2. Application This Standard Operating Procedure applied to the entire Quality Management System as it relevant
OECD SERIES ON PRINCIPLES OF GOOD LABORATORY PRACTICE AND COMPLIANCE MONITORING Number 11. Advisory Document of the Panel on Good Laboratory Practice
Unclassified ENV/MC/CHEM(98)16 ENV/MC/CHEM(98)16 Or. Eng. Unclassified Organisation de Coopération et de Développement Economiques OLIS : 21-Jan-1998 Organisation for Economic Co-operation and Development
GMP Training Course Quality Control. 20-21 October 2009. Lesley Graham Senior Inspector (UK)
GMP Training Course Quality Control 20-21 October 2009 Lesley Graham Senior Inspector (UK) Quality Control GMP in the QC Laboratory Certificates of Analysis Dealing with out of specification results Parametric
Roles & Responsibilities of the Sponsor
Roles & Responsibilities of the Sponsor Developed by Center for Cancer Research, National Cancer Institute, NIH Endorsed by the CTN SIG Leadership Group Objectives Funding for clinical research comes from
PROCEDURE(S) OF THE NATIONAL GLP OFFICE
PROCEDURE(S) OF THE NATIONAL GLP OFFICE National GLP Office implements the National GLP Programme under the direct control of the National GLP Compliance Monitoring Authority (NGCMA), Department of Science
The Quality System for Drugs in Germany
The Quality System for Drugs in Germany Prof. Dr. Harald G. Schweim Head of Department for Drug Regulatory Affairs Institute for Pharmacy, University of Bonn Former President of the German Federal Institute
International GMP Requirements for Quality Control Laboratories and Recomendations for Implementation
International GMP Requirements for Quality Control Laboratories and Recomendations for Implementation Ludwig Huber, Ph.D. [email protected] Overview GMP requirements for Quality Control laboratories
Chapter 48 Bioresearch Monitoring
Chapter 48 Bioresearch Monitoring Subject GOOD LABORATORY PRACTICE (Nonclinical Laboratories) Implementation Date February 21, 2001 Completion Date Continuing Product Codes 51Z or 52Z 45Z, 46Z 57Z, 99Z
OECD SERIES ON PRINCIPLES OF GOOD LABORATORY PRACTICE AND COMPLIANCE MONITORING NUMBER 10 GLP CONSENSUS DOCUMENT
GENERAL DISTRIBUTION OCDE/GD(95)115 OECD SERIES ON PRINCIPLES OF GOOD LABORATORY PRACTICE AND COMPLIANCE MONITORING NUMBER 10 GLP CONSENSUS DOCUMENT THE APPLICATION OF THE PRINCIPLES OF GLP TO COMPUTERISED
Good Clinical Laboratory Practice (GCLP) An international quality system for laboratories which undertake the analysis of samples from clinical trials
Good Clinical Laboratory Practice (GCLP) An international quality system for laboratories which undertake the analysis of samples from clinical trials Vanessa Grant and Tim Stiles VERSION 2 Published by
Manual 074 Electronic Records and Electronic Signatures 1. Purpose
1. Purpose The purpose of this document is to provide an interpretation of FDA 21 CFR Part 11, Electronic Records; Electronic Signatures (ER/ES) and to provide guidance for acceptable practices in the
Annex 7 Guidelines for the preparation of a contract research organization master file
World Health Organization WHO Technical Report Series, No. 957, 2010 Annex 7 Guidelines for the preparation of a contract research organization master file Background 1. General information 2. Quality
OMCL Network of the Council of Europe QUALITY ASSURANCE DOCUMENT
OMCL Network of the Council of Europe QUALITY ASSURANCE DOCUMENT PA/PH/OMCL (08) 69 3R Full document title and reference Document type VALIDATION OF COMPUTERISED SYSTEMS Legislative basis - CORE DOCUMENT
Title:: Effective GMP AUDITS for APIs and Formulation Pharma Companies By G.Sundar-Director/Consultant PharmQA Compliance solutions
WELCOME Title:: Effective GMP AUDITS for APIs and Formulation Pharma Companies By G.Sundar-Director/Consultant PharmQA Compliance solutions Contents: Introduction GMP Audit GMP Audit plan GMP Auditing
B i o s o l u t i o n s
B i o s o l u t i o n s Implementation of pharmatracker TM : A case study Prepared by Ocimum Biosolutions Ocimumbio Solutions August 2006 All rights reserved. 2 B i o s o l u t i o n s an ISO 9001:2000
OECD DRAFT ADVISORY DOCUMENT 16 1 THE APPLICATION OF GLP PRINCIPLES TO COMPUTERISED SYSTEMS FOREWARD
OECD DRAFT ADVISORY DOCUMENT 16 1 THE APPLICATION OF GLP PRINCIPLES TO COMPUTERISED SYSTEMS FOREWARD 1. The following draft Advisory Document will replace the 1995 OECD GLP Consensus Document number 10
GOOD LABORATORY PRACTICE (GLP) GUIDELINES FOR THE VALIDATION OF COMPUTERISED SYSTEMS. Working Group on Information Technology (AGIT)
GOOD LABORATORY PRACTICE (GLP) GUIDELINES FOR THE VALIDATION OF COMPUTERISED SYSTEMS Working Group on Information Technology (AGIT) Release Date: 14 December 2007 Version: 02 AGIT - Validation of Computerised
Overview. Disasters are happening more frequently and Recovery is taking on a different perspective.
Overview Disasters are happening more frequently and Recovery is taking on a different perspective. Defining a Disaster/Disaster Recovery Basic requirements in preparing for a disaster The role of Quality
GOOD LABORATORY PRACTICE (GLP)
AGIT Guidelines for the Change Management and Risk Assessment 1 / 11 GOOD LABORATORY PRACTICE (GLP) GUIDELINES FOR CHANGE MANAGEMENT AND RISK ASSESSMENT OF VALIDATED COMPUTERISED SYSTEMS IN A GLP ENVIRONMENT
How To Manage An Electronic Standard Operating Procedure
AGIT Management of electronic SOPs 1 / 14 GOOD LABORATORY PRACTICE (GLP) GUIDELINES FOR THE MANAGEMENT OF ELECTRONIC STANDARD OPERATING PROCEDURES (SOPs) IN A GLP ENVIRONMENT Working Group Information
ANY TISSUE BANK USA. Revision: 3
1 of 5 1. Scope 1.1. This work instruction provides specific direction for qualifying vendors as required in SOP-5, Purchasing Components. 2. Definitions and Acronyms 2.1. Definitions for terms used in
GOOD DOCUMENTATION AND QUALITY MANAGEMENT PRINCIPLES. Vimal Sachdeva Technical Officer (Inspector), WHO Prequalification of Medicines Programme
GOOD DOCUMENTATION AND QUALITY MANAGEMENT PRINCIPLES Vimal Sachdeva Technical Officer (Inspector), WHO Prequalification of Medicines Programme Contents 1. Why good documentation is essential? 2. What constitutes
GOOD LABORATORY PRACTICE UK GLPMA POLICY ON THE USE OF NON-GLP FACILITIES FOR THE CONDUCT OF STUDY PHASES.
GOOD LABORATORY PRACTICE UK GLPMA POLICY ON THE USE OF NON-GLP FACILITIES FOR THE CONDUCT OF STUDY PHASES. Introduction The information provided in this document is designed to supplement the guidance
PROPOSED UPDATED TEXT FOR WHO GOOD MANUFACTURING PRACTICES FOR PHARMACEUTICAL PRODUCTS: MAIN PRINCIPLES (JANUARY 2013)
January 2013 RESTRICTED PROPOSED UPDATED TEXT FOR WHO GOOD MANUFACTURING PRACTICES FOR PHARMACEUTICAL PRODUCTS: MAIN PRINCIPLES (JANUARY 2013) DRAFT FOR COMMENTS Please address any comments on this proposal
Computerized System Audits In A GCP Pharmaceutical Laboratory Environment
IVTGXP_july06.qxd 6/28/06 1:09 PM Page 36 Computerized System Audits In A GCP Pharmaceutical Laboratory Environment By Maintaining data integrity for both clinical laboratory processes and patient data
The role, duties and responsibilities of clinical trials personnel Monitoring: rules and recommendations
The role, duties and responsibilities of clinical trials personnel Monitoring: rules and recommendations Maria Luisa Paoloni OPBG Clinical & Research Services Monitoring and Responsible of monitoring:
MANUAL FOR INSPECTORS MONITORING COMPLIANCE WITH THE PRINCIPLES OF GOOD LABORATORY PRACTICE
MANUAL FOR INSPECTORS MONITORING COMPLIANCE WITH THE PRINCIPLES OF GOOD LABORATORY PRACTICE by the Inspection Procedures Group of the National and Länder Working Party on GLP (since 1997: NLWP on GLP and
1 The quality management system (QMS) is the corner stone of compliance to GMP. The QMS is made up of several documents, that when followed ensures the GMP compliance of the process, facility and company.
Procedure for Procurement and Receipt
Procedure for Procurement and Receipt 1.0 Purpose - To ensure that all supplies, equipment and services purchased by the State Crime Laboratory (Laboratory) are properly procured and received. 2.0 Scope
The EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Russia
The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Russia Question 1: What laws or regulations apply to an application for conducting a clinical
RECOMMENDATION ON THE CONTENT OF THE TRIAL MASTER FILE AND ARCHIVING
RECOMMENDATION ON THE CONTENT OF THE TRIAL MASTER FILE AND ARCHIVING July 2006 TABLE OF CONTENTS Page 1. Introduction 2 2. Scope 2 3. Documents to be archived 2 4. Quality of essential documents 10 5.
Job Profile Clinical Research Associate III (CRA)
PART 1 - PROFILE You are an experienced CRA with a strong background in Clinical Research who is passionate about drug development and are seeking a challenging and rewarding career in a quality focussed
A Guide to Archiving of Electronic Records
A Guide to Archiving of Electronic Records 18th February 2014 A Guide to Archiving of Electronic Records The Scientific Archivists Group (SAG) formed a Working Party to develop guidance to assist in the
Best Practices In Ensuring Quality Standards When Outsourcing To Contract Manufacturers, Licensees And Consultants
Best Practices In Ensuring Quality Standards When Outsourcing To Contract Manufacturers, Licensees And Consultants Alex D. Kanarek, PhD BioProcess Technology Consultants, Inc. Strategic Institute Quality
GLP Records Storage and Retrieval
GLP Records Storage and Retrieval Cindy Green BBS UNITED, ALEX HAYDEN/GETTY IMAGES GLP Topics addresses topics associated with good laboratory practice requirements. We intend this column to be a useful
Best Practice In A Change Management System
Quality & Compliance Associates, LLC Best Practice In A Change Management System President Quality & Compliance Associates, LLC Change Control and Its Role in a Continuous Improvement Environment 3 Benefits
gsop-32-02 - Vendor Assessment SOP page 1 of 10
gsop-32-02 - Vendor Assessment SOP page 1 of 10 Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust VENDOR ASSESSMENT Research & Development
STANDARD OPERATING PROCEDURE FOR RESEARCH. Management of Essential Documents and Trial Folders
STANDARD OPERATING PROCEDURE FOR RESEARCH Management of Essential Documents and Trial Folders Author Linda Ward Author s Job Title QA Coordinator Division Department Version number 2 Ref SOP/CLN/001/2
Welcome Computer System Validation Training Delivered to FDA. ISPE Boston Area Chapter February 20, 2014
Welcome Computer System Validation Training Delivered to FDA ISPE Boston Area Chapter February 20, 2014 1 Background Training Conducted on April 24, 2012 Food & Drug Administration Division of Manufacturing
Reflection paper for laboratories that perform the analysis or evaluation of clinical trial samples
28 February 2012 EMA/INS/GCP/532137/2010 GCP Inspectors Working Group Reflection paper for laboratories that perform the analysis or evaluation of clinical trial Draft agreed by GCP Inspectors Working
ASSESSMENT OF QUALITY RISK MANAGEMENT IMPLEMENTATION
PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 038-1 26 March 2012 AIDE-MEMOIRE ASSESSMENT OF QUALITY RISK MANAGEMENT IMPLEMENTATION PIC/S March 2012 Reproduction
Library Guide: Pharmaceutical GMPs
Library Guide: Pharmaceutical GMPs Table of Contents Overview...3 Courses Listed by Functional Area... 4 Course Descriptions: A Step-by-Step Approach to Process Validation (PHDV79)... 7 A Tour of the FDA
5 FAH-5 H-510 CONFIGURATION MANAGEMENT
5 FAH-5 H-500 CONFIGURATION MANAGEMENT 5 FAH-5 H-510 PROJECT DEVELOPMENT AND CHANGE CONTROL (CT:ITS-4; 06-21-2012) (Office of Origin: IRM/BMP/GRP/GP) (Updated only to revise Office of Origin) 5 FAH-5 H-511
Organisation de Coopération et de Développement Économiques Organisation for Economic Co-operation and Development
Unclassified ENV/JM/MONO(2016)13 ENV/JM/MONO(2016)13 Unclassified Organisation de Coopération et de Développement Économiques Organisation for Economic Co-operation and Development 22-Apr-2016 English
This SOP may also be used by staff from other NHS areas, or organisations, with prior agreement.
Standard Operating Procedure: SOP Number: SOP-QA-32 Version No: 1 Author: Date: (Gary Cooper, Named Sponsor Archivist, NHS Grampian and University of Aberdeen) 1-9-15 Approved by: Date: 1-9-15 (Professor
The Global Guideline for GCP Audit
The Global Guideline for GCP Audit Author: JSQA: Hiroyasu Yamashita, e-mail: [email protected] Reviewed and Acknowledged by: BARQA: Patricia Fitzgerald, e-mail: [email protected]
EMA Clinical Laboratory Guidance - Key points and Clarifications PAUL STEWART
EMA Clinical Laboratory Guidance - Key points and Clarifications PAUL STEWART Framework Labs generate data that are used to make decisions on the safety and efficacy of medicinal products; consequently,
Conducting a Gap Analysis on your Change Control System. Presented By Miguel Montalvo, President, Expert Validation Consulting, Inc.
Conducting a Gap Analysis on your Change Control System Presented By Miguel Montalvo, President, Expert Validation Consulting, Inc. Standards, Regulations, Guidelines related to Change Control Management
EUROPEAN INDUSTRIAL PHARMACISTS GROUP
EUROPEAN INDUSTRIAL PHARMACISTS GROUP Guide to Good Regulatory Practice Acknowledgments: Valérie LACAMOIRE, Conseil Central de la section B de l Ordre des Pharmaciens Kelsey MOWER, Industrial Pharmacists
Regulations for Handling Samples and Laboratory Testing from R&D through Phase III Clinical Trials
Regulations for Handling Samples and Laboratory Testing from R&D through Phase III Clinical Trials Ron Hinkel, Director Quality Systems BioReliance Inc. Patti Rossman, President Globiox Purpose Keep pace
The use of computer systems
Technology Update Computer Systems Validation, Part 1 Software Purchase and GCP Compliance Teri Stokes Teri Stokes, PhD, is senior consultant and director of GXP International, 131 Sudbury Road, Concord,
How To Archive Data From A Research Project
P erspective S pecial Focus: e - solutions in bioanalysis Challenges in archiving electronic bioanalytical data supporting GLP studies in a CRO The purpose of this article is to articulate the fundamental
The Study Site Master File and Essential Documents
The Study Site Master File and Essential Documents Standard Operating Procedure Office of Health and Medical Research Queensland Health SOP reference: 002 Version number: 1 Effective date: 01 June 2010
GOOD CLINICAL LABORATORY PRACTICE (GCLP)
Special Programme for Research & Training in Tropical Diseases (TDR) sponsored by U N I C E F / U N D P / W o r l d B a n k / W H O GOOD CLINICAL LABORATORY PRACTICE (GCLP) Special Programme for Research
Recent Updates on European Requirements and what QPs are expected to do
Recent Updates on European Requirements and what QPs are expected to do QP Forum 28/29 November 2013, Lisbon Dr. Bernd Renger Modified: Georg Goestl 1 Written Conformation for API-Import Actual Status
Quality Assurance. Disclosure for Lilli Møller Andersen. No relevant financial relationships exist for any issue mentioned in this presentation
Quality Assurance Disclosure for Lilli Møller Andersen No relevant financial relationships exist for any issue mentioned in this presentation Agenda Quality Assurance Quality Management System Quality
Computerised Systems. Seeing the Wood from the Trees
Computerised Systems Seeing the Wood from the Trees Scope WHAT IS A COMPUTERISED SYSTEM? WHY DO WE NEED VALIDATED SYSTEMS? WHAT NEEDS VALIDATING? HOW DO WE PERFORM CSV? WHO DOES WHAT? IT S VALIDATED -
In terms of food quality, you want to be absolutely confident that the results you get are reliable.
In terms of food quality, you want to be absolutely confident that the results you get are reliable. Welcome to the centre of excellence for food analysis Our strong core competences in food chemistry
World Health Organization Prequalification of Medicines
Dr André van Zyl World Health Organization Prequalification of Medicines Manufacturers meeting April 2011 Head of Inspections [email protected] 1 WHO GMP In this presentation: Background and Introduction
Quality Agreement. by and between. Supplier Name. Address: and. Client Name: Address:
NOTE TO USERS This Quality Agreement template was developed by the Bulk Pharmaceutical Task Force (BPTF), an affiliate organization of the Society of Chemical Manufacturers and Affiliates (SOCMA), as a
Barnett International and CHI's Inaugural Clinical Trial Oversight Summit June 4-7, 2012 Omni Parker House Boston, MA
Barnett International and CHI's Inaugural Clinical Trial Oversight Summit June 4-7, 2012 Omni Parker House Boston, MA This presentation is the property of DynPort Vaccine Company LLC, a CSC company, and
VENDOR QUALIFICATION. Fran Rabe Manager Quality Assurance University of Minnesota Molecular and Cellular Therapeutics
VENDOR QUALIFIATION Fran Rabe Manager Quality Assurance University of Minnesota Molecular and ellular Therapeutics 1 Vendor Qualification - Why Provides security to ensure product and service consistently
Standard Operating Procedure on Training Requirements for staff participating in CTIMPs Sponsored by UCL
Page 1 of 10 Standard Operating Procedure on Training Requirements for staff participating in CTIMPs Sponsored by UCL SOP ID Number: Effective Date:01/08/2012 Version Number & Date of Authorisation: V02,
TEMPLATE DATA MANAGEMENT PLAN
TEMPLATE DATA MANAGEMENT PLAN ICRIN (QM sub group) Version: XX Date: XXXXXXX Page 1 of 6 1.0 Document Ownership The Data Management Plan (DMP) will be initiated and subsequently owned by the Data Manager
The EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2012) Sweden
The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe Sweden Question 1: What laws or regulations apply to an application for conducting a clinical trial in Sweden?
Disaster Recovery & Business Continuity Related, but NOT the Same! Teri Stokes, Ph.D., Director GXP International
Disaster Recovery & Business Continuity Related, but NOT the Same! Teri Stokes, Ph.D., Director GXP International BCP Definitions Business Continuity Plan: An ongoing process supported by senior management
Working with ICH Quality Guidelines - the Canadian Perspective
Working with ICH Quality Guidelines the Canadian Perspective Krishnan Tirunellai, Ph. D. Bureau of Pharmaceutical Sciences Therapeutic Products Directorate Health Canada December 3, 2008 Outline Introduction
Data Governance Planning PDA 12 May 2015
Data Governance Planning PDA 12 May 2015 1 Agenda Overview of Data Integrity Assurance of Data Data Governance The Data Governance Plan Questions 2 Overview of Data Integrity 3 Data Information derived
Archiving of Research Documentation
Suspension, Termination & Completion Standard Operating Procedure VERSION / REVISION: 2.0 EFFECTIVE DATE: 28 05 12 REVIEW DATE: 28 05 14 AUTHOR(S): CONTROLLER: APPROVED BY: Clinical Trials Manager; Recruitment
CRM s and the Dilemma of the 2nd Source. Shawn Kassner, Sr Product Manager Tim Miller, Sr Organic Chemist Phenova, A Phenomenex Company
CRM s and the Dilemma of the 2nd Source Shawn Kassner, Sr Product Manager Tim Miller, Sr Organic Chemist Phenova, A Phenomenex Company What are we talking about? ISO 17025 requirements for labs and CRM
Quality Management System Certification. Understanding Quality Management System (QMS) certification
Quality Management System Certification Understanding Quality Management System (QMS) certification The medical device manufacturing sector is one of the most regulated sectors in which significant quality
GCP - Records Managers Association
GCP - Records Managers Association Guidance on the Scanning and Destruction of Paper Records 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 The introduction
Equipment Qualification
Equipment Qualification Deborah L. Griffin, BA Laboratory Supervisor, HSCLab Hillman Cancer Center University of Pittsburgh Cancer Institute University of Pittsburgh Medical Center Equipment Qualification
COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS
COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS Primer CONTENTS INTRODUCTION...3 QUALITY AND COMPLIANCE IN QUALITY CONTROL LABORATORIES...5 Compliance
Electronic Raw Data and the Use of Electronic Laboratory Notebooks
7th WRIB- M-2 Workshop Electronic Raw Data and the Use of Electronic Laboratory Notebooks Ron Shoup Outline for Today Raw Data- defining it, creating it, and keeping it for posterity Hybrid Data- paper,
Clinical database/ecrf validation: effective processes and procedures
TITOLO SLIDE Testo Slide Testo Slide Testo Slide Clinical database/ecrf validation: effective processes and procedures IV BIAS ANNUAL CONGRESS Padova September, 26 th 2012 PQE WORKSHOP: What's new in Computerized
Auditing as a Component of a Pharmaceutical Quality System
Auditing as a Component of a Pharmaceutical Quality System Tim Fields Conducting internal audits (or self inspections) and external audits of suppliers and outsourcing operations are key elements of a
Monitoring & Auditing of Clinical Trials. Sponsored by Center for Cancer Research National Cancer Institute
Monitoring & Auditing of Clinical Trials Sponsored by Center for Cancer Research National Cancer Institute Objectives Guidelines suggest that following the good clinical research practice of monitoring/auditing
Job description. Job title. Process Engineer. Responsible to. Process Engineering Manager. Hours/sessions per week 37.
Job description Job title Directorate Pay band Responsible to Base/location Process Engineer Production SEO Process Engineering Manager Porton Hours/sessions per week 37.5 Job type Permanent INTRODUCTION
QUALITY SYSTEM REQUIREMENTS FOR PHARMACEUTICAL INSPECTORATES
PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 002-3 25 September 2007 RECOMMENDATION ON QUALITY SYSTEM REQUIREMENTS FOR PHARMACEUTICAL INSPECTORATES PIC/S September
GOVERNANCE AND THE EHR4CR INSTITUTE
GOVERNANCE AND THE EHR4CR INSTITUTE Dipak Kalra EuroRec, University College London Christian Ohmann, European Clinical Research Infrastructure Network (ECRIN) Electronic Health Records for Clinical Research
Supplier Quality Assurance
Supplier Quality Assurance Preface We strive to continually improve our process performance by meeting quality objectives. It is imperative that our suppliers operate under the zero defects and 100% on
ICH Q7 GMP for Active Pharmaceutical Ingredients
National University of Singapore Academy of GxP Excellence (NUSAGE) and PharmEng Technology Presents ICH Q7 GMP for Active Pharmaceutical Ingredients Part of the Pharmaceutical Biotechnology Training Courses
MHRA GMP Data Integrity Definitions and Guidance for Industry January 2015
MHRA GMP Data Integrity Definitions and Guidance for Industry Introduction: Data integrity is fundamental in a pharmaceutical quality system which ensures that medicines are of the required quality. This
